MyFinsight
Home
Blog
About
Discontinued operations
$4,053,236
Net cash provided by
operating activities
$168,740
(-96.44%↓ Y/Y)
Canceled cashflow
$3,884,496
Accounts payable and
other current...
$1,454,343
(172.04%↑ Y/Y)
Accounts receivable
-$842,384
(39.16%↑ Y/Y)
Other long-term
liabilities
$557,170
(40539.68%↑ Y/Y)
something is missing
$464,737
Amortization of operating
lease right-of-use...
$196,139
(-65.61%↓ Y/Y)
Share-based compensation
$77,866
(-49.73%↓ Y/Y)
Net decrease in cash
and cash...
-$7,144,843
(-280.67%↓ Y/Y)
Canceled cashflow
$168,740
something is missing
$763,300
Net cash provided by
(used in) operating...
-$3,497,471
something is missing
-$387,025
Canceled cashflow
$3,592,639
Net cash used in
financing activities
-$5,387,165
(5.10%↑ Y/Y)
Net cash used in
investing activities
-$1,926,418
(-104.43%↓ Y/Y)
Canceled cashflow
$763,300
Net income (loss)
-$4,274,430
(-933.26%↓ Y/Y)
Depreciation and
amortization expense
-$1,204,664
(-158.32%↓ Y/Y)
Inventories, net
$703,861
(138.71%↑ Y/Y)
Other current assets
and other assets
$427,093
(166.73%↑ Y/Y)
Increase in cash
surrender value of life...
$253,211
(525.10%↑ Y/Y)
Operating lease
liabilities
-$226,851
(48.49%↑ Y/Y)
Net cash used in
financing activities from...
-$5,301,734
Discontinued operations
-$848,731
Net cash used in
investing activities from...
-$1,842,132
Discontinued operations
-$145,459
Payments on line of credit
$5,240,733
(-47.78%↓ Y/Y)
Net (increase)
decrease of investment in...
$1,754,228
Additions to property and
equipment
$38,283
(-48.35%↓ Y/Y)
Back
Back
Cash Flow
CUMBERLAND PHARMACEUTICALS INC (CPIX)
CUMBERLAND PHARMACEUTICALS INC (CPIX)
source: myfinsight.com